Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Birsen Pınar Yıldız"'
Publikováno v:
Cam & Sakura Medical Journal, Vol 3, Iss 2, Pp 53-61 (2023)
Objective: We aimed to investigate the combined use of D-dimer and neutrophil-to-lymphocyte ratio (NLR) as a prognostic index-coronavirus disease (PRI-COVID) in COVID-19 patients to predict mortality. Material and Methods: We included 152 COVID-19 pa
Externí odkaz:
https://doaj.org/article/b15722c3ce3d4768b78b5220ccc317e0
Publikováno v:
Cam & Sakura Medical Journal, Vol 3, Iss 1, Pp 12-18 (2023)
Objective: The study assessed the nutritional status of non-critically ill coronavirus disease-2019 (COVID-19) patients with pneumonia using the nutritional risk screening 2002 (NRS-2002) score and evaluate ıts impact on prognosis. Material and Meth
Externí odkaz:
https://doaj.org/article/8fcbd87c3ba14ef4a0e7ffa84653eb64
Publikováno v:
Respiratory Case Reports. 11:73-76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b4b1a22bf530252fabee90327970e3e
https://doi.org/10.5505/respircase.2022.37084
https://doi.org/10.5505/respircase.2022.37084
Publikováno v:
Malawi Medical Journal; Vol. 33 No. 4 (2021); 276-280
BackgroundAccording to the World Health Organisation reports (WHO), COPD is the third leading cause of overall in the World by 2020. AimWe aimed to determine the prognostic predictors of 90-day mortality after an initial exacerbation in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4b50c52a419b57ab0cf06c4cc66a7da
https://doi.org/10.4314/mmj.v33i4.8
https://doi.org/10.4314/mmj.v33i4.8
Autor:
Hakan Gunen, Nurdan Kokturk, Sibel Naycı, Sevket Ozkaya, Birsen Pınar Yıldız, Onur Turan, Aziz Gumus, Metin Akgun, Alev Gurgun, Candan Ogus, Arzu Mirici, Elif Sen, Nazan Bayram, Volkan Eken, Hakan Erkus
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease.
Purpose: GOLD 2019 proposed a novel treatment decision tool for follow-up based on the predominant trait (exacerbation or dyspnea) of patients, alongside treatment escalation and de-escalation strategies. This study was designed to provide an up-to-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb71823214df466ea46a82122e8afe2
https://www.dovepress.com/the-co-mind-study-chronic-obstructive-pulmonary-disease-management-in--peer-reviewed-fulltext-article-COPD
https://www.dovepress.com/the-co-mind-study-chronic-obstructive-pulmonary-disease-management-in--peer-reviewed-fulltext-article-COPD
Publikováno v:
Respiratory Case Reports. Jun2022, Vol. 11 Issue 2, p73-76. 4p.
Autor:
Onur, Seda Tural, Natoli, Antonino, Dreger, Bettina, Arınç, Sibel, Sarıoğlu, Nurhan, Çörtük, Mustafa, Karadoğan, Dilek, Şenyiğit, Abdurrahman, Yıldız, Birsen Pınar, Köktürk, Nurdan, Barıs, Serap Argun, Cengiz, Sümeyye Kodalak, Polatli, Mehmet
Publikováno v:
International Journal of COPD; Nov2023, Vol. 18, p2785-2794, 10p
Publikováno v:
Cam ve Sakura Medical Journal; 2023, Vol. 3 Issue 2, p53-61, 9p
Autor:
Gunen, Hakan, Kokturk, Nurdan, Naycı, Sibel, Ozkaya, Sevket, Yıldız, Birsen Pınar, Turan, Onur, Gumus, Aziz, Akgun, Metin, Gurgun, Alev, Ogus, Candan, Mirici, Arzu, Sen, Elif, Bayram, Nazan, Eken, Volkan, Erkus, Hakan
Publikováno v:
International Journal of COPD; Aug2022, Vol. 17, p1883-1895, 13p
Autor:
Søren C. Dam
The Pharmacological Guide to Montelukast opens by presenting the most recent updates on the improvement of montelukast stability and bioavailability, along with some innovative formulations produced by this research. Montelukast is a leukotriene modi
